Bharat Biotech vaccine News

Nasal Covid-19 Vaccine: The first intranasal Covid-19 vaccine 'Incovac' developed in the country will be started from January 26. It has been made by Swadeshi Bharat Biotech.

Another vaccine has been approved in the war against the corona epidemic. DCGI has approved Bharat Biotech's nasal vaccine for Corona. This will be the country's first nasal vaccine.

Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week. The first trial was started in the age group of 12-18 years followed by the age group of 6-12 years and 2-6 years which are currently undergoing trials.

The full data from studies on Covaxin's neutralisation of variants are already published.

In the third phase of the coronavirus vaccination drive which begins from March 1, the government is aiming to expand the vaccination drive to the general public of the nation. People with co-morbid conditions will need to carry a medical certificate to receive the vaccination.

NITI Aayog has promulgated a price range of Rs 300-500 which the private hospitals can charge for the two COVID-19 vaccines. The government has been procuring SII's Covishield for around Rs 210 per dose while the cost of Covaxin is around Rs 290 for a shot.

The NITI Aayog has promulgated a price range of Rs 300-500 for two Covid vaccines that would be available for the priority group at private facilities. In the third phase of vaccination set to begin from March 1 Covid vaccines will be available in private hospitals as well.

In case of any adverse events or serious adverse events, you will be provided medically recognised standard of care in the government designated and authorised centres/hospitals. The compensation for the serious adverse event will be paid by the sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine The central licensing authority has granted permission for the sale or distribution of Covaxin for restricted use in emergency situations in the public interest as an abundant caution, in clinical trial mod

A SpiceJet flight carrying the vaccines landed at the Delhi airport around 10 am. Civil Aviation Minister Hardeep Singh Puri said four airlines will operate nine flights to transport the vaccine. A 'puja' was performed before the vehicles left the facility.

DCGI on Sunday approved Covishield and Covaxin for restricted use in India. Covaxin is developed by Bharat Biotech. Serum Intitute and Bharat Biotech vaccines have to be administered in two doses.

DCGI on Sunday approved Covishield and Covaxin for restricted use in India. Covaxin is developed by Bharat Biotech. Serum Intitute and Bharat Biotech vaccines have to be administered in two doses.